Outcomes and Treatment of Lumbosacral Spinal Tuberculosis: A Retrospective Study of 53 Patients

PLoS One. 2015 Jun 29;10(6):e0130185. doi: 10.1371/journal.pone.0130185. eCollection 2015.

Abstract

Study strategy: A retrospective clinic study.

Purpose: To evaluate the efficacy of conservative and surgical treatment for lumbosacral tuberculosis.

Methods: This study retrospectively reviewed 53 patients with lumbosacral tuberculosis who were treated in our institution between January 2005 and January 2011. There were 29 males and 24 females with average ages of 37.53 ± 17.28 years (range 6-72 years). 11 patients were given only anti-TB drugs; the remainder underwent anterior debridement, interbody fusion with and without instrumentation, or one-stage anterior debridement combined with posterior instrumentation. Outcome data for these patients included neurologic status, lumbosacral angle, erythrocyte sedimentation rate value(ESR) and C-reactive protein value(CRP) were assessed before and after treatment.

Results: The mean lumbosacral angles were 23.00°± 2.90° in the conservatively treated patients and 22.36°± 3.92o in the surgically treated patients. At the final follow-up, this had improved to 24.10o ± 2.96° in the conservatively treated patients and 28.13° ± 1.93° in the surgically treated patients (all P < 0.05). There were statistically significant differences before and after treatment in terms of ESR and CRP (all P < 0.05). All patients achieved bone fusion. The mean follow-up period was 32.34 ± 8.13 months (range 18 to 55 months). The neurological deficit did not worsen in any of the patients.

Conclusions: It has been proven that conservative and surgical treatments are safe and effective and produce good clinical outcomes for patients with lumbosacral tuberculosis. The advantages of operation include thoroughness of debridement, decompression of the spinal cord, and adequate spinal stabilization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Animals
  • Antitubercular Agents / therapeutic use
  • Back Pain
  • Blood Sedimentation
  • C-Reactive Protein / biosynthesis
  • Child
  • Debridement
  • Decompression, Surgical
  • Female
  • Follow-Up Studies
  • Humans
  • Lumbar Vertebrae / pathology
  • Male
  • Middle Aged
  • Radiography
  • Retrospective Studies
  • Sacrum / pathology
  • Spinal Fusion*
  • Treatment Outcome
  • Tuberculosis, Spinal / diagnostic imaging
  • Tuberculosis, Spinal / drug therapy*
  • Tuberculosis, Spinal / surgery*
  • Young Adult

Substances

  • Antitubercular Agents
  • C-Reactive Protein

Grants and funding

The authors acknowledge support from the Guangxi Science Funds NO. 2012GXNSFAA053087, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.